†Results from 17 patients were not obtained (6 in the
CHA group and 11 in the CSU-AE group).
‡Results from 5 patients were not obtained (1 in the
IH-AEE group and 4 in the CSU-AE group).
§Results from 18 patients were not obtained.
AAS7 level was categorized as follows: no episodes (0), low (1–6),
moderate (7–18), high (19–105).
UAS7 levels were categorized as follows: no episodes (0), low (1–6),
moderate (7–27), high (28–42).
Statistically significant differences are highlighted in bold.